National-Level Medical Services Always at Hand at the Wuwei Heavy Ion Center

National-Level Medical Services Always at Hand at the Wuwei Heavy Ion Center

Recently, a team of leading experts from top-tier medical centers in China, including Professor Ma Lulin and Professor Liu Ke from Peking University Third Hospital, as well as Professor Wang Ping from the First Affiliated Hospital of Guangzhou Medical University, have successively visited our hospital to perform a series of highly complex and precise surgeries. This marks a breakthrough in our hospital's efforts to connect with top-tier national medical resources and enhance regional capabilities in diagnosing and treating major diseases, allowing residents in Wuwei and surrounding areas to access cutting-edge medical technology services close to home.

Radical Surgery for Advanced Bladder Cancer: On December 21, Professor Ma Lulin, an authoritative expert in the field of urology at Peking University Third Hospital, successfully performed a robot-assisted laparoscopic radical cystectomy on a patient with advanced bladder cancer using our hospital's domestically produced Toumai surgical robot system. This highly complex surgery showcased our hospital's technical prowess in treating challenging tumors.

Precision Treatment for High-Risk Benign Prostatic Hyperplasia: Mr. Yang, who suffered from urinary retention due to severe benign prostatic hyperplasia, underwent a transurethral resection of the prostate performed by Professor Liu Ke from Peking University Third Hospital on December 20. Professor Liu Ke has extensive experience in minimally invasive treatments for complex and high-risk benign prostatic hyperplasia, ensuring precise and efficient surgery.

Minimally Invasive Treatment for Complex Hepatobiliary Diseases: Ms. Nian was admitted to the hospital with recurrent jaundice and cirrhosis 18 years after undergoing surgery for common bile duct stones. Due to a history of multiple abdominal surgeries, she suffered from severe adhesions. On December 19, Professor Wang Ping, a pioneer in the minimally invasive treatment of complex biliary diseases at the First Affiliated Hospital of Guangzhou Medical University, successfully performed percutaneous transhepatic bile duct stone fragmentation and removal, along with bile duct stricture incision and dilation, using his innovative "percutaneous transhepatic one-stage biliary fistulation (PTOBF)" technique. This minimally invasive approach offers minimal trauma and faster recovery, paving a new path for treating complex hepatobiliary stones.

The successful completion of this series of highly complex surgeries is attributed not only to the exceptional skills of top national experts but also to the advanced technological platforms our hospital has been diligently developing in recent years. The combination of "national treasures" such as the domestically produced Toumai surgical robot system and the heavy ion therapy system with the expertise of leading specialists has formed a comprehensive system characterized by "expert guidance, technical support, and equipment assurance."

In the future, our hospital will remain committed to the "patient-centered" service philosophy, deepen collaboration with top-tier medical teams, strengthen discipline development and talent cultivation, continuously enhance regional medical service capabilities, and contribute new and greater efforts to safeguarding the health and well-being of the people in the Hexi Corridor.

Ma Lulin​

Second-grade Professor at Peking University, Doctoral Supervisor, and Postdoctoral Co-Supervisor; Vice President of the Haidian Campus of Peking University Third Hospital. With nearly four decades of expertise in urology, he is a leading authority in renal transplantation and complex urological oncology in China. He has achieved international excellence in living-donor kidney transplantation and simultaneous pancreas-kidney transplantation. His profound skills are demonstrated in high-complexity procedures such as robot-assisted/laparoscopic resection of large adrenal tumors, radical resection of renal cell carcinoma with inferior vena cava tumor thrombus (performing approximately 80 such surgeries annually, with over 200 cumulative cases—a globally leading volume), nerve-sparing radical prostatectomy, and Studer orthotopic bladder reconstruction. Having treated over ten thousand patients, he enjoys an exceptional reputation in the field.

Liu Ke​

Associate Chief Physician and Medical Doctor in the Department of Urology at Peking University Third Hospital; Head of the Benign Prostatic Hyperplasia (BPH) Specialist Group. He specializes in minimally invasive and laser surgeries for BPH, with particular expertise in managing complex high-risk cases (e.g., elderly patients, multiple comorbidities, large-volume prostates) using transurethral laser enucleation. Additionally, he has extensive experience in diagnosing and treating voiding dysfunctions and urinary incontinence in the elderly, minimally invasive endoscopic management of urinary stones, surgeries for urinary tract strictures, and conventional operations for urological tumors.

Wang Ping​

Deputy Director of the Hepatobiliary Surgery Department at the First Affiliated Hospital of Guangzhou Medical University, Chief Physician, and Doctoral Supervisor. He focuses on the surgical treatment of hepatobiliary-pancreatic tumors and complex biliary diseases, and pioneered the percutaneous transhepatic one-stage biliary fistulation (PTOBF) technique for complicated hepatobiliary stones. He is highly skilled in performing challenging procedures such as radical resections for liver cancer, cholangiocarcinoma, and pancreatic cancer; fluorescence-guided anatomic hepatectomy; R0 resection of hilar cholangiocarcinoma; and regional pancreaticoduodenectomy. He also has rich experience in laparoscopic hepatobiliary surgery, liver transplantation, and surgery for portal hypertension.